Skip to main content
Erschienen in: World Journal of Urology 4/2010

01.08.2010 | Original Article

Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis

verfasst von: T. Ürge, O. Hes, J. Ferda, Z. Chudáček, V. Eret, M. Michal, M. Brunelli, G. Martignoni, M. Hora

Erschienen in: World Journal of Urology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Types 1 and 2 by Delahunt of papillary renal cell carcinoma (PRCC) are traditionally differentiated. An oncocytic variant of PRCC (O-PRCC) has recently been described. We compare clinical data of O-PRCC with other subtypes of PRCC such as the main tumour size, necrotic changes, presence of pseudocapsula and real extrarenal growth in retrospective study.

Methods

From 1/1992 to 10/2009, 1,398 patients with 1,436 renal tumours were surgically treated in our institution. PRCCs were described in 109 (7.6%). Among PRCC, O-PRCCs were in 12 (11%), PRCC type 1 in 86 (78.9%), PRCC type 2 in 8 (7.3%) and others in 3 (2.8%) cases.

Results

The patient’s mean age with O-PRCC (M:F ratio = 2:1) was 67.5 ± 10.9 versus 63.5 ± 14.1 in type 1 and 57.9 ± 5.7 in type 2, the mean tumour size was 35 ± 12 mm versus 47 ± 22 and 37 ± 17, respectively. The follow-up of O-PRCC is 35.3 ± 12.3 months and all cases are without recurrence. We did not find any pseudocapsula in O-PRCC but it was a major sign of PRCC type 1 (32.6%). Huge microscopic necrotic changes were described in 33.3% of O-PRCC, in 33.7% of PRCC type 1 and 62.5% of PRCC type 2. Extrarenal growth was found only in 16.7% O-PRCC versus 40.7% in PRCC type I.

Conclusions

None of the O-PRCC had pseudocapsula and none had massive necroses in comparison of O-PRCC with PRCC types I and II. Extrarenal growth in O-PRCC is relatively rare. The malignant potential of O-PRCC is low.
Literatur
1.
Zurück zum Zitat Mancilla-Jimenez R, Stanley RJ, Balth RA (1976) Papillary renal cell carcinoma. A clinical, radiological, and pathologic study of 34 cases. Cancer 38(6):2469–2480CrossRefPubMed Mancilla-Jimenez R, Stanley RJ, Balth RA (1976) Papillary renal cell carcinoma. A clinical, radiological, and pathologic study of 34 cases. Cancer 38(6):2469–2480CrossRefPubMed
2.
Zurück zum Zitat Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumours. Mod Pathol 10:537–544PubMed Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumours. Mod Pathol 10:537–544PubMed
3.
Zurück zum Zitat Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS (2001) Expression profiling of renal epithelial neoplasms: a method for tumour classification and discovery of diagnostic molecular markers. Am J Pathol 158:1639–1651PubMed Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS (2001) Expression profiling of renal epithelial neoplasms: a method for tumour classification and discovery of diagnostic molecular markers. Am J Pathol 158:1639–1651PubMed
4.
Zurück zum Zitat Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chreátien Y, Thiounn N, Dufour B (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170:764–767CrossRefPubMed Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chreátien Y, Thiounn N, Dufour B (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170:764–767CrossRefPubMed
5.
Zurück zum Zitat Yang XJ, Tan MH, Kim HL, Ditlev JA et al (2005) A molecular classification of papillary renal cell carcinoma. Cancer Res 65(13):5628–5637CrossRefPubMed Yang XJ, Tan MH, Kim HL, Ditlev JA et al (2005) A molecular classification of papillary renal cell carcinoma. Cancer Res 65(13):5628–5637CrossRefPubMed
6.
Zurück zum Zitat Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32:590–595CrossRefPubMed Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32:590–595CrossRefPubMed
7.
Zurück zum Zitat Yang F, Richter J, Schraml P, Bubendorf L, Gasser T, Kauter G, Mihatsch MJ, Moch H (1998) Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol 153(5):1767–1773 Yang F, Richter J, Schraml P, Bubendorf L, Gasser T, Kauter G, Mihatsch MJ, Moch H (1998) Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol 153(5):1767–1773
8.
Zurück zum Zitat Pignot G, Elie C, Cunquy S et al (2007) Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69(2):230–235CrossRefPubMed Pignot G, Elie C, Cunquy S et al (2007) Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69(2):230–235CrossRefPubMed
9.
Zurück zum Zitat Lefévre M, Couturier J, Sibony M, Bazille C, Boyer K, Callard P, Vieillefond A, Allory Y (2005) Adult papillary renal tumour with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 29(12):1576–1581CrossRefPubMed Lefévre M, Couturier J, Sibony M, Bazille C, Boyer K, Callard P, Vieillefond A, Allory Y (2005) Adult papillary renal tumour with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 29(12):1576–1581CrossRefPubMed
10.
Zurück zum Zitat Hes O, Brunelli M, Michal M, Cossu Rocca P, Hora M, Chilosi M, Mina M, Boudova L, Menestrina F, Martignoni G (2006) Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 10(3):133–139CrossRefPubMed Hes O, Brunelli M, Michal M, Cossu Rocca P, Hora M, Chilosi M, Mina M, Boudova L, Menestrina F, Martignoni G (2006) Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 10(3):133–139CrossRefPubMed
11.
Zurück zum Zitat Kunju LP, Wonjo K, Wolf JS, Cheby L et al (2008) Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol 39:96–101CrossRefPubMed Kunju LP, Wonjo K, Wolf JS, Cheby L et al (2008) Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol 39:96–101CrossRefPubMed
12.
Zurück zum Zitat Park BH, Ro JY, Park WS et al (2009) Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course. Pathol Int 59:137–146CrossRefPubMed Park BH, Ro JY, Park WS et al (2009) Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course. Pathol Int 59:137–146CrossRefPubMed
13.
Zurück zum Zitat Mai KT, Kohler DM, Robertson SJ et al (2008) Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma. Pathol Int 58(3):164–168CrossRefPubMed Mai KT, Kohler DM, Robertson SJ et al (2008) Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma. Pathol Int 58(3):164–168CrossRefPubMed
14.
Zurück zum Zitat Masuzawa N, Kishimoto M, Nishimura A, Shichiri Y, Yanagisawa A (2008) Oncocytic renal cell carcinoma having papillotubular growth: rare morphological variant of papillary renal cell carcinoma. Pathol Int 58:300–305CrossRefPubMed Masuzawa N, Kishimoto M, Nishimura A, Shichiri Y, Yanagisawa A (2008) Oncocytic renal cell carcinoma having papillotubular growth: rare morphological variant of papillary renal cell carcinoma. Pathol Int 58:300–305CrossRefPubMed
15.
Zurück zum Zitat Hora M, Hes O, Reischig T, Ürge T, Klečka J, Ferda J, Michal M, Eret V (2008) Tumours in end-stage kidney. Transplant Proc 40(10):3354–3358CrossRefPubMed Hora M, Hes O, Reischig T, Ürge T, Klečka J, Ferda J, Michal M, Eret V (2008) Tumours in end-stage kidney. Transplant Proc 40(10):3354–3358CrossRefPubMed
16.
Zurück zum Zitat Hora M, Hes O, Klečka J, Boudová L, Chudáček Z, Kreuzberg B, Michal M (2004) Rupture of papillary renal cell carcinoma. Scan J Urol Nephrol 38(6):481–484CrossRef Hora M, Hes O, Klečka J, Boudová L, Chudáček Z, Kreuzberg B, Michal M (2004) Rupture of papillary renal cell carcinoma. Scan J Urol Nephrol 38(6):481–484CrossRef
17.
Zurück zum Zitat Schafter LR, Bach AM, Snyder ME, Kattan MW, Russo P (2006) The impact of tumour location on the histological subtype of renal cortical tumours. BJU Int 98:63–66CrossRef Schafter LR, Bach AM, Snyder ME, Kattan MW, Russo P (2006) The impact of tumour location on the histological subtype of renal cortical tumours. BJU Int 98:63–66CrossRef
18.
Zurück zum Zitat Hora M, Hes O, Ürge T, Klečka J, Eret V, Ferda J, Chudáček Z (2007) Papillary renal cell carcinoma are treated more frequently by laparoscopic partial nephrectomy due to their exophytic growth than non-papillary tumours. Eur Urol Suppl 6(2):236CCrossRef Hora M, Hes O, Ürge T, Klečka J, Eret V, Ferda J, Chudáček Z (2007) Papillary renal cell carcinoma are treated more frequently by laparoscopic partial nephrectomy due to their exophytic growth than non-papillary tumours. Eur Urol Suppl 6(2):236CCrossRef
19.
Zurück zum Zitat Ferda J, Hora M, Hes O, Ferdovaá E, Kreuzberg B (2007) Assessment of the kidney tumour vascular supply by two-phase MDCT-angiography. Eur J Radiol 62(2):295–301CrossRefPubMed Ferda J, Hora M, Hes O, Ferdovaá E, Kreuzberg B (2007) Assessment of the kidney tumour vascular supply by two-phase MDCT-angiography. Eur J Radiol 62(2):295–301CrossRefPubMed
20.
Zurück zum Zitat Israel G, Bosniak M (2005) An update of the Bosniak renal cyst classification system. Urology 66:484–488CrossRefPubMed Israel G, Bosniak M (2005) An update of the Bosniak renal cyst classification system. Urology 66:484–488CrossRefPubMed
Metadaten
Titel
Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis
verfasst von
T. Ürge
O. Hes
J. Ferda
Z. Chudáček
V. Eret
M. Michal
M. Brunelli
G. Martignoni
M. Hora
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 4/2010
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-010-0563-1

Weitere Artikel der Ausgabe 4/2010

World Journal of Urology 4/2010 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.